Log in to search using one of your social media accounts:

 

Key Technical Documents: Ebola Response
World Health Organization. 05/2017 This one-page document provides quick access to key technical documents and publications on Ebola for responders. Topics include Surveillance, Contact Tracing, and Laboratory; Case Management and Infection Prevention and Control; Vaccines; Therapeutics; and Travel and Points of Entry. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - August 15, 2017 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

Einstein Researchers Awarded Three NIH Grants Totaling $12 Million to Fight Virulent Viruses
August 11, 2017—BRONX, NY—The NIH has awarded Einstein researchers three grants totaling more than $12 million to protect against three deadly viruses—Ebola, Marburg and hantavirus. Research collaborations betweenKartik Chandran, Ph.D., professor of microbiology& immunology and the Harold and Muriel Block Faculty Scholar in Virology, andJonathan Lai, Ph.D., associate professor of biochemistry, have led to novel approaches for developing vaccines and treatments. (Source: Einstein News)
Source: Einstein News - August 11, 2017 Category: Universities & Medical Training Source Type: news

Morning Break: Bat Crazy for Ebola; Exercise Pill? Addiction Vaccine
(MedPage Today) -- Health news and commentary from around the Web gathered by the MedPage Today staff (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - August 11, 2017 Category: Psychiatry Source Type: news

Einstein researchers awarded 3 NIH grants totaling $12 million to fight virulent viruses
(Albert Einstein College of Medicine) The NIH has awarded Einstein researchers three grants totaling more than $12 million to protect against three deadly viruses -- Ebola, Marburg and hantavirus. Research collaborations between Kartik Chandran, Ph.D., professor of microbiology& immunology and the Harold and Muriel Block Faculty Scholar in Virology, and Jonathan Lai, Ph.D. associate professor of biochemistry, have led to novel approaches for developing vaccines and treatments. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 11, 2017 Category: International Medicine & Public Health Source Type: news

Community engagement drives Ebola vaccine trial in Sierra Leone
To ensure the right person takes an Ebola trial vaccine at the right time in Sierra Leone, an EU-industry funded project is employing a combination of low-tech and high-tech community engagement strategies. Today, 450 adults and 96 adolescents are successfully enrolled in a two-stage vaccine trial. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - August 1, 2017 Category: Research Source Type: news

2017 FDA (Food and Drug Administration) Science Forum Webcast
U.S. Food and Drug Administration. 06/19/2017 This Web page provides information, videos, and transcripts from the 2017 Food and Drug Administration Science Forum Webcast on May 31-June 1, 2017. Sessions topics included Development of Mouse Models to Assess Efficacy and Potency of Zika Virus Therapeutics; Development of Total and Neutralizing Anti-Ebola Virus Antibody Assays for Deployment in West Africa to Evaluate Clinical Trials of Medical Countermeasures, including Vaccines and Immunotherapies; and Use of an FDA Real-Time Mobile Communication Platform System during Medical Countermeasure Events: RAPID. (Video or Multim...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - July 19, 2017 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

When an emerging disease becomes endemic
Epidemics, such as HIV in the early 1980s and Ebola in 2014, inspire decisive government investment and action, and individual and societal concern, sometimes bordering on panic. By contrast, endemic diseases, such as HIV in 2017 and tuberculosis, struggle to maintain the same attention. For many, the paradox is that endemic disease, in its totality, continues to impose a far higher public health burden than epidemic disease. Overall, the swift political response to epidemics has resulted in success. It has proven possible to eradicate epidemic diseases, often without the availability of vaccines and other biomedical techn...
Source: ScienceNOW - July 13, 2017 Category: Science Authors: Medley, G. F., Vassall, A. Tags: Medicine, Diseases special/review Source Type: news

Three-Zone Biosecurity Offers New Hope to Indonesian Farmers
James McGrane, FAO ECTAD Indonesia Team Leader, at his office in Jakarta. Credit: Kanis Dursin/IPSBy Kanis DursinJAKARTA, Indonesia, Jul 10 2017 (IPS)Poultry farmer Bambang Sutrisno Setiawan had long heard about biosecurity but never gave serious thought to it, even when the highly pathogenic avian influenza H5N1 forced him to cull thousands of his layer chickens in 2003 and 2009.Eighteen years into the business, however, Bambang, who is called Ilung by friends, is now converting his second farm into a three-zone biosecurity poultry with a strong conviction that it is the only way to save his business amid continued threat...
Source: IPS Inter Press Service - Health - July 10, 2017 Category: International Medicine & Public Health Authors: Kanis Dursin Tags: Asia-Pacific Economy & Trade Featured Food & Agriculture Headlines Health Projects avian flu biosafety Food and Agriculture Organization of the United Nations (FAO) Improving the lives of rural populations: better nutrition & agricultu Source Type: news

CEPI (Coalition for Epidemic Preparedness Innovation) Ebola Vaccines Regulatory Science Meeting
Coalition for Epidemic Preparedness Innovations. 05/22/2017 This 10-page report summarizes a regulatory scientific meeting held on March 22, 2017, to address the regulatory science gaps on the Ebola vaccines. It aimed to clarify the current gaps in scientific knowledge and data needed to support licensure of Ebola vaccines via pathways other than traditional approval, i.e., approval in the absence of clinical efficacy data. Participants looked into future regulatory scientific research areas which will be further refined and taken forward in smaller task forces. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medi...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - July 2, 2017 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

Guidance Document: Questionnaire on Regulatory Science Issues for the Development of Emerging Infectious Disease (EID) Vaccines
Coalition for Epidemic Preparedness Innovations. 03/29/2017 This four-page document provides guidance on the completion of the CEPI questionnaire on regulatory science issues for development of emerging infectious disease (EID) vaccines. Partners with an interest in securing regulatory approval/licensure of EID vaccines are invited to provide comment on the regulatory scientific issues for the development of EID vaccines. The document provides background information and issues on the prioritized pathogens Ebola, Lassa, Nipah, and Middle East respiratory syndrome (MERS). (PDF) (Source: Disaster Lit: Resource Guide for Disas...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - July 2, 2017 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

Community Health Workers: Forgotten No More
June 21, 2017A new global campaign is pushing for salaries, benefits, and formal employment for these crucial health workers.They crisscross the villages, urban settlements, hills, valleys and plains, sometimes on foot, sometimes on bicycles.They wear T-shirts with health messages. They carry bags of tablets, syrups, and health information materials. They mobilize communities to go for vaccinations. They distribute mosquito nets. They supply contraceptives. They accompany women to antenatal clinics and delivery rooms and ensure that they deliver their babies safely.They go by various names such as community health workers ...
Source: IntraHealth International - June 21, 2017 Category: International Medicine & Public Health Authors: mnathe Source Type: news

Ebola vaccine developed in Canada shows promising results
(Canadian Medical Association Journal) A phase 1 randomized controlled trial has found an Ebola virus disease vaccine, developed in Canada, was well-tolerated with no safety concerns, and high antibodies were present in participants six months after immunization. The study, led by Canadian researchers, is published in Canadian Medical Association Journal. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 19, 2017 Category: Infectious Diseases Source Type: news

e-PROTECT Occupational Health and Safety
World Health Organization. 06/2017 This occupational health and safety course covers the basic information needed to protect yourself when deploying to countries with Ebola virus disease. Five modules cover how Ebola is transmitted, what the symptoms are, how it is diagnosed, and what treatments are currently available; infection prevention and control; staff safety, including medical clearance, vaccinations, and other precautions; medical incident management, or what to do if you experience sudden onset of symptoms, if there has been an exposure, or if medical evacuation is needed; and how to carry out debriefing and foll...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - June 16, 2017 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

Cholera epidemic in Yemen reaches ‘unprecedented’ scale
Outbreak set to be ‘worst of the century’, warn agencies Related items fromOnMedica Healthcare ‘a tactic of war’ in Iraq and Syria Eastern Mediterranean conflict jeopardising decades of health gains World ’s first malaria vaccine to be piloted World ‘not prepared’ for Zika and Ebola (Source: OnMedica Latest News)
Source: OnMedica Latest News - June 9, 2017 Category: UK Health Source Type: news

Insane Texas Bill That Attacks Abortion From All Sides Just Became Law
On Tuesday, Texas Gov. Greg Abbott signed into law a far-reaching anti-abortion bill that critics have slammed as “cruel” and “unconstitutional.” After a landmark Supreme Court ruling that struck down two Texas abortion restrictions last June, legislators in that state came back with a vengeance, considering some 50 anti-choice measures over the last several months. (Rewire called it an “anti-choice blitz.”) But the newly passed Senate Bill 8 stands out from the rest for the startling breadth with which it attacks abortion rights.  The Center for Reproductive Rights has already pled...
Source: Healthy Living - The Huffington Post - June 7, 2017 Category: Consumer Health News Source Type: news

Antibodies from Ebola survivor could lead to treatments and vaccines
Antibodies from an Ebola survivor protected animals from deadly ebolaviruses and could help inform the development of potential treatments and vaccines. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - June 5, 2017 Category: Consumer Health News Source Type: news

Congo-Kinshasa: WHO, DR Congo Approve Ebola Vaccine to Stop Outbreak
[Guardian] - Researchers investigate possible link between pigs, current EVD cases (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 1, 2017 Category: African Health Source Type: news

DR Congo approves Ebola vaccine to counter outbreak; UN-trained volunteers to educate local populations
To contain the latest outbreak of the Ebola virus in the Democratic Republic of Congo (DRC), the United Nations Children ’ s Fund (UNICEF) provided technical support to 145 volunteers of the Congolese Red Cross and community health workers to deliver lifesaving information to local populations in remote areas along the Central African Republic border. (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - May 30, 2017 Category: International Medicine & Public Health Source Type: news

Congo Approves Use of Ebola Vaccination to Fight Outbreak Congo Approves Use of Ebola Vaccination to Fight Outbreak
Democratic Republic of Congo's health ministry has approved the use of a new Ebola vaccine to counter an outbreak of the hemorrhagic fever in its northeast that has killed four people, a spokesman said on Monday.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 30, 2017 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Congo-Kinshasa: Govt Approves Experimental Ebola Vaccine Use
[Deutsche Welle] The Democratic Republic of Congo has given the green light to an experimental vaccine to combat an ongoing Ebola outbreak. While the vaccine is not licensed, it has shown promising signs in a clinical trial. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 30, 2017 Category: African Health Source Type: news

DRC approves new vaccine to counter Ebola virus
The Democratic Republic of Congo (DRC) has given approval for the use of a new vaccine to fight against the ongoing Ebola outbreak in the country's north-eastern region. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - May 29, 2017 Category: Pharmaceuticals Source Type: news

WATCH: Ebola vaccine provides protection against deadly disease
In a major trial, rVSV-ZEBOV caused mild side effects including headache, fatigue and muscle pain, but those side effects don't appear to be long term. (Source: ABC News: Health)
Source: ABC News: Health - May 29, 2017 Category: Consumer Health News Tags: Health Source Type: news

Congo approves use of Ebola vaccine to fight outbreak
Congo's health ministry has approved the use of a new Ebola vaccine (Source: CBC | Health)
Source: CBC | Health - May 29, 2017 Category: Consumer Health News Tags: News/Health Source Type: news

Congo approves use of Ebola vaccination to fight outbreak
KINSHASA (Reuters) - Democratic Republic of Congo's health ministry has approved the use of a new Ebola vaccine to counter an outbreak of the hemorrhagic fever in its northeast that has killed four people, a spokesman said on Monday. (Source: Reuters: Health)
Source: Reuters: Health - May 29, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Congo to test experimental Ebola vaccine as disease re-emerges
WHO hopes Merck drug will quell latest outbreak following successful Guinea trial (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - May 23, 2017 Category: Pharmaceuticals Source Type: news

Suspected Cases of Ebola Rise to 29 in Democratic Republic of Congo
Aid workers are trying to reach a remote part of the country, where there have been three deaths from the virus. (Source: NYT Health)
Source: NYT Health - May 18, 2017 Category: Consumer Health News Authors: DENISE GRADY Tags: Ebola Virus Vaccination and Immunization World Health Organization Rollin, Pierre E Congo, Democratic Republic of (Congo-Kinshasa) Central African Republic Source Type: news

Researchers Discover First Human Antibodies That Work Against All Ebolaviruses
May 18, 2017—(BRONX, NY)—After analyzing the blood of a survivor of the 2013-16 Ebola outbreak, a team of scientists from academia, industry and the government has discovered the first natural human antibodies that can neutralize and protect animals against all three major disease-causing ebolaviruses. The findings, published online today in the journalCell, could lead to the first broadly effective ebolavirus therapies and vaccines. (Source: Einstein News)
Source: Einstein News - May 18, 2017 Category: Universities & Medical Training Source Type: news

Another Step Toward Ebola Protection
Discovery of critical human antibodies may put scientists closer to new vaccines, treatments Source: HealthDay Related MedlinePlus Pages: Ebola (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - May 18, 2017 Category: Consumer Health News Source Type: news

Suspected Cases of Ebola Rise to 18 in Democratic Republic of Congo
Aid workers are trying to reach a remote part of the country, where there have been three deaths from the virus and about 400 possible contacts. (Source: NYT Health)
Source: NYT Health - May 18, 2017 Category: Consumer Health News Authors: DENISE GRADY Tags: Ebola Virus Vaccination and Immunization World Health Organization Rollin, Pierre E Congo, Democratic Republic of (Congo-Kinshasa) Central African Republic Source Type: news

Health Officials Discuss Sending Experimental Ebola Vaccine To Congo
A World Health Organization spokesman on Sunday confirmed two Ebola cases in the Democratic Republic of Congo on Sunday, bringing the outbreak’s total to 19 suspected and confirmed cases, including three deaths. Health agencies are now in preliminary discussions about sending an experimental vaccine to the outbreak area. The vaccine, developed in the wake of the 2014 West Africa outbreak, was deemed highly effective last year following a large-scale trial of the vaccine in Guinea in 2015. It has not yet been dispatched to the DRC, but health agencies are considering sending the 300,000 available vaccine dos...
Source: Healthy Living - The Huffington Post - May 15, 2017 Category: Consumer Health News Source Type: news

WHO preparing authorization, logistics for Ebola vaccination in Congo if needed
LONDON (Reuters) - The World Health Organization (WHO) said on Monday its experts have not yet decided whether to use newly developed vaccines to try to contain an outbreak of Ebola in Congo, but officials are making preparations just in case. (Source: Reuters: Health)
Source: Reuters: Health - May 15, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Vaccine alliance says 300,000 doses of Merck's Ebola shot available for emergencies
LONDON (Reuters) - The GAVI global vaccine alliance said on Friday some 300,000 emergency doses of an Ebola vaccine developed by Merck could be available in case of a large-scale outbreak,  after the World Health Organization confirmed a fatal case in Congo. (Source: Reuters: Health)
Source: Reuters: Health - May 12, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

At Least 1 Person Dead From New Ebola Outbreak In Democratic Republic Of Congo
One person has died from a new outbreak of the Ebola virus in the Democratic Republic of Congo, the World Health Organization confirmed Friday. The country has reported nine suspected cases of the virus and three deaths since April 22, according to WHO communications officer Christoper Lindmeier. Out of the three deaths, one tested positive for Ebola. The #Ebola case in the Democratic Republic of Congo was confirmed by a national reference laboratory in Kinshasa #DRC— WHO (@WHO) May 12, 2017 The cases were discovered in Aketi, a remote region without much access to health facilities, WHO communications offi...
Source: Science - The Huffington Post - May 12, 2017 Category: Science Source Type: news

Target Product Profile for Vaccine Platform Technologies
World Health Organization. 04/24/2017 This two-page document provides an overview of characteristics that should be met by vaccine platform technologies aiming to be used reactively in emergency situations. It is provided in the context of the 2014-16 Ebola epidemic, which demonstrated the need for an ability to develop effective interventions in a timely manner for control of severe emerging infectious diseases. It presents four hypothetical scenarios and how these could affect target product profile (TPP) characteristics. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 9, 2017 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

WHO chief praises Guineans for help with Ebola vaccine
The head of the World Health Organization praised Guineans on Thursday for their role in helping to develop a vaccine against the deadly Ebola virus. (Source: CBC | Health)
Source: CBC | Health - May 4, 2017 Category: Consumer Health News Tags: News/Health Source Type: news

The World Is Not Ready for the Next Pandemic
Across China, the virus that could spark the next pandemic is already circulating. It’s a bird flu called H7N9, and true to its name, it mostly infects poultry. Lately, however, it’s started jumping from chickens to humans more readily–bad news, because the virus is a killer. During a recent spike, 88% of people infected got pneumonia, three-quarters ended up in intensive care with severe respiratory problems, and 41% died. What H7N9 can’t do–yet–is spread easily from person to person, but experts know that could change. The longer the virus spends in humans, the better the chance that i...
Source: TIME.com: Top Science and Health Stories - May 4, 2017 Category: Consumer Health News Authors: Bryan Walsh Tags: Uncategorized CDC Disease ebola Gates Foundation MERS outbreak pandemic Zika Source Type: news

Foot pain is common and excruciating. Here ’ s how to treat it.
Have you ever felt smug about meeting your daily step target? Imagine if you met your 11,000-step target every day continuously for more than a week — that's what I did. But my feet paid a price for it. There were a lot of illnesses I was afraid of coming down with in my 10-week internship […]Related:What makes someone donate a kidney to a stranger?A mysterious illness kills 11 young people in Liberia, where Ebola ragedU.S. yellow fever vaccine supply will be gone by this summer, but CDC has a plan (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - May 4, 2017 Category: Consumer Health News Source Type: news

Opening remarks at the Ebola vaccines for Guinea and the world event
4 May 2017 – At an event held in Conakry, Guinea, Dr Margaret Chan thanked the presidents of Guinea, Liberia, and Sierra Leone for supporting the development of a new Ebola vaccine which provides substantial protection against this highly lethal disease. The close collaboration of Guinea’s national authori ties was a catalysing factors in successful implementation of the WHO vaccine trial. Dr Chan also described several spillover initiatives that are leaving the world better prepared for the next inevitable Ebola outbreak. (Source: WHO Director-General speeches)
Source: WHO Director-General speeches - May 4, 2017 Category: Global & Universal Tags: director-general [subject], director-general [subject], director-general [subject], ebola [subject], ebola haemhorragic fever, ebola virus, ebola fever, ebola virus disease, African Region [region], Guinea [country], Speech [doctype] Source Type: news

SAGE (Strategic Advisory Group of Experts on Immunizations) Meeting of April 2017
World Health Organization. 04/2017 This Web page provides presentations from the April 2017 meeting of the Strategic Advisory Group of Experts on Immunizations (SAGE), including reports from other advisory committees. Session topics included the use of oral cholera vaccines, an update with the development of Ebola vaccines and implications to inform future policy recommendations, and a review of recent diphtheria outbreaks. (Text) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 2, 2017 Category: Global & Universal Authors: The U.S. National Library of Medicine Source Type: news

You just learned you have breast cancer. What ’ s next?
Steven Katz, an internist at the University Michigan, researches how medical decisions are made. Over the last dozen years, he has surveyed 10,000 patients and their doctors to better understand how they discuss a diagnosis and decide to proceed. “Women have taught me a lot,” says Katz. Sorting out various options can be “very confusing […]Related:What makes someone donate a kidney to a stranger?A mysterious illness kills 11 young people in Liberia, where Ebola ragedU.S. yellow fever vaccine supply will be gone by this summer, but CDC has a plan (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - April 29, 2017 Category: Consumer Health News Source Type: news

People who donate a kidney to a stranger have unusual values and beliefs
'They see it as an obvious choice,' one researcher said.Related:A mysterious illness kills 11 young people in Liberia, where Ebola ragedU.S. yellow fever vaccine supply will be gone by this summer, but CDC has a planTrump nominee to head FDA clears key panel, moves to full Senate for vote (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - April 28, 2017 Category: Consumer Health News Source Type: news

What makes someone donate a kidney to a stranger?
'They see it as an obvious choice,' one researcher said.Related:A mysterious illness kills 11 young people in Liberia, where Ebola ragedU.S. yellow fever vaccine supply will be gone by this summer, but CDC has a planTrump nominee to head FDA clears key panel, moves to full Senate for vote (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - April 28, 2017 Category: Consumer Health News Source Type: news

A mysterious illness kills 11 young people in Liberia, where Ebola raged
World Health Organization officials said Friday that they are investigating a troubling report out of Liberia of a “cluster of unexplained illnesses and deaths” in an area several hours from Monrovia. Since April 24, at least 17 people have fallen ill with fever, vomiting, headache, diarrhea. Eleven have died and five are still hospitalized at the Francis Grant […]Related:People who donate a kidney to a stranger have unusual values and beliefsU.S. yellow fever vaccine supply will be gone by this summer, but CDC has a planTrump nominee to head FDA clears key panel, moves to full Senate for ...
Source: Washington Post: To Your Health - April 28, 2017 Category: Consumer Health News Source Type: news

U.S. yellow fever vaccine supply will be gone by this summer, but CDC has a plan
U.S. health officials on Friday warned of a new complication in the fight to contain mosquito-borne viruses spreading around the world: The country's supply of yellow fever vaccine is dwindling and will likely be completely gone by this summer — with no way to make more because of a manufacturing problem. The shortage comes at a troubling time. Multiple […]Related:People who donate a kidney to a stranger have unusual values and beliefsA mysterious illness kills 11 young people in Liberia, where Ebola ragedTrump nominee to head FDA clears key panel, moves to full Senate for vote (Source: Was...
Source: Washington Post: To Your Health - April 28, 2017 Category: Consumer Health News Source Type: news

Early blood signatures of vaccine immunogenicity
Within seven days of vaccination, a blood test early after vaccination can predict whether vaccines based on living, modified viruses have had the desired effect. This is one of the results of a new study on systems analysis of immune responses induced by a highly promising vaccine against Ebola. This result can inform and accelerate rational development of other new vaccines based on living viruses. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 26, 2017 Category: Science Source Type: news

Early blood signatures of vaccine immunogenicity
(University of Gothenburg) Within seven days of vaccination, a blood test early after vaccination can predict whether vaccines based on living, modified viruses have had the desired effect. This is one of the results of a new study from a large European research collaboration on systems analysis of immune responses induced by a highly promising vaccine against Ebola in which the University of Gothenburg is participating. This result can inform and accelerate rational development of other new vaccines based on living viruses. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 26, 2017 Category: Global & Universal Source Type: news

Frog slime could protect us against future flu epidemic
Conclusion This study has identified a substance in the mucus secreted by a south Indian frog which can kill certain types of flu virus. Researchers often turn to natural substances with known health-giving properties to find potential new drugs for humans. For example, aspirin was developed based on a compound found in willow bark – which had been used in traditional medicine for hundreds of years. Some other drugs – such as some chemotherapy and anticlotting drugs – have also been developed from chemicals found in plants. By isolating the substances that have an effect the researchers can make sure...
Source: NHS News Feed - April 19, 2017 Category: Consumer Health News Tags: Heart/lungs Medication Medical practice Source Type: news

The demands of disease drive science
Producers aim much R&D at targets such as Ebola and HIV for which no vaccine exists (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - April 18, 2017 Category: Pharmaceuticals Source Type: news

Measuring the safety, efficacy of a vaccine against Ebola virus disease
The 2014--2015 Ebola epidemic affected several countries in West Africa, leading to the death of more than 11,000 people. Although this epidemic of Ebolavirus disease is over, there is no knowing if, when or where another may strike. It is therefore more important than ever to find a reliable vaccine against this deadly disease. Research on vaccines, which was ongoing during the epidemic in West Africa, is now yielding promising results. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 18, 2017 Category: Science Source Type: news